Pharmacological application of caffeine inhibits TGF-β-stimulated connective tissue growth factor expression in hepatocytes via PPARγ and SMAD2/3-dependent pathways
- 1 November 2008
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 49 (5) , 758-767
- https://doi.org/10.1016/j.jhep.2008.03.029
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Activation of TGF‐β within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factorJournal of Cellular and Molecular Medicine, 2008
- Coffee drinking and hepatocellular carcinoma riskHepatology, 2007
- Differential effects of TGF-β on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytesJournal of Hepatology, 2007
- PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression1Acta Pharmacologica Sinica, 2006
- Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United StatesGastroenterology, 2005
- Mechanisms of TGF-β Signaling from Cell Membrane to the NucleusCell, 2003
- Prostacyclin derivatives prevent the fibrotic response to TGFβ2 by inhibiting the Ras/MEK/ERK pathwayThe FASEB Journal, 2002
- Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-βNature Cell Biology, 2002
- The modular architecture of a new family of growth regulators related to connective tissue growth factorPublished by Wiley ,2001
- Variation of immunocytochemical expression of transforming growth factor (TGF)-β in hepatocytes in culture and liver slicesCell and tissue research, 1996